The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Atlas Venture Associates Ix, Llc since 2017.
This trader's CIK number is 1671207.
At the time of last reporting, Atlas Venture Associates Ix, Llc was the 10% Owner of Surface Oncology, Inc.. (stock ticker symbol SURF).
Also see all insider trading activities at Surface Oncology, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | UMRX | 94,052 | $1,128,624 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | NTLA | 0 | $0 | 171,132 | $2,729,299 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | SURF | 0 | $0 | 1,700,000 | $30,770,000 | 0 | $0 |
| 2018 | SURF | 100,000 | $1,500,000 | 0 | $0 | 0 | $0 |
1. Cogent Biosciences, Inc. (UMRX)
2. Intellia Therapeutics, Inc. (NTLA)
3. Surface Oncology, Inc. (SURF)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-04-03 | UMRX | Buy | 94,052 | 12.00 | 1,128,624 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-07-11 | NTLA | Sale | 80,000 | 16.07 | 1,285,600 |
| 2017-07-10 | NTLA | Sale | 40,000 | 16.17 | 646,880 |
| 2017-07-07 | NTLA | Sale | 30,000 | 16.77 | 502,979 |
| 2017-03-10 | NTLA | Sale | 5,504 | 14.06 | 77,408 |
| 2017-03-09 | NTLA | Sale | 15,628 | 13.85 | 216,432 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-12-17 | SURF | Sale | 1,700,000 | 18.10 | 30,770,000 |
| 2018-04-23 | SURF | Buy | 100,000 | 15.00 | 1,500,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Atlas Venture Associates Ix, Llc (10% Owner of Surface Oncology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.